Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
INVO

INVO - INVO BioScience, Inc. Stock Price, Fair Value and News

$1.72+0.51 (+42.15%)
Market Closed

64/100

INVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

64/100

INVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.98

Target 3M

$0.85

Target 6M

$0.89

INVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INVO Price Action

Last 7 days

101.2%

Last 30 days

87.4%

Last 90 days

181.0%

Trailing 12 Months

-70.9%

INVO RSI Chart

INVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INVO Valuation

Market Cap

26.0M

Price/Earnings (Trailing)

-0.9

Price/Sales (Trailing)

3.75

EV/EBITDA

-1

Price/Free Cashflow

-3.37

INVO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.98

Target 3M

$0.85

Target 6M

$0.89

INVO Fundamentals

INVO Revenue

Revenue (TTM)

6.9M

Rev. Growth (Yr)

22.6%

Rev. Growth (Qtr)

-5.72%

INVO Earnings

Earnings (TTM)

-29.0M

Earnings Growth (Yr)

-62.18%

Earnings Growth (Qtr)

49.96%

INVO Profitability

Operating Margin

52.75%

EBT Margin

-387.89%

Return on Equity

-495.09%

Return on Assets

-153.76%

Free Cashflow Yield

-29.69%

INVO Investor Care

Shares Dilution (1Y)

206.55%

Diluted EPS (TTM)

-4.82

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20256.6M6.6M6.9M0
20244.2M5.8M6.2M6.5M
20231.0M1.2M1.9M3.0M
20223.6M3.6M3.6M822.2K
20211.5M1.4M1.3M4.2M
20201.5M1.1M1.2M1.0M
2019579.7K1.1M1.3M1.5M
2018334.0K363.9K420.7K494.4K
201785.0K159.9K210.3K282.1K
201626.2K26.1K41.4K50.9K
201510.5K13.9K11.7K11.7K
201428.5K27.0K31.5K16.6K
201353.4K44.3K41.0K27.1K
201249.7K40.6K31.4K56.4K
201100071.5K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About INVO BioScience, Inc.

INVO
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.
 CEO
 WEBSITEinvobio.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES15

INVO BioScience, Inc. Frequently Asked Questions

INVO is the stock ticker symbol of INVO BioScience, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of INVO BioScience, Inc. is 26.02 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check INVO's fair value in chart for subscribers.

The fair value guage provides a quick view whether INVO is over valued or under valued. Whether INVO BioScience, Inc. is cheap or expensive depends on the assumptions which impact INVO BioScience, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INVO.

As of Tue Jan 27 2026, INVO's PE ratio (Price to Earnings) is -0.9 and Price to Sales (PS) ratio is 3.75. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INVO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, INVO BioScience, Inc. has provided -0.542 (multiply by 100 for percentage) rate of return.